Lawrence Brenner
Cardiovascular Disease · Corpus Christi, TXNPI 1225010317
Payments from drug & device makers
Across 442 payments — averaging $35.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Abiomed$3K
- Abbott$901
- Johnson & Johnson$485
- Biotronik Inc.$317
- Merck$292
- plus $3K from 27 others
What the payments were for
- Food & beverage$15,475100%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 239 | $7,590 |
| Abiomed | 48 | $3,399 |
| Abbott | 44 | $901 |
| Johnson & Johnson | 25 | $485 |
| Biotronik Inc. | 5 | $317 |
| Merck | 19 | $292 |
| Esperion Therapeutics, Inc. | 6 | $229 |
| W. L. Gore & Associates, Inc. | 2 | $224 |
| Biosense Webster, Inc. | 2 | $216 |
| Bard Peripheral Vascular, Inc. | 3 | $204 |
| EKOS Corporation | 3 | $152 |
| Shockwave Medical, Inc | 3 | $144 |
| Cardiovascular Systems Inc. | 2 | $144 |
| Impulse Dynamics (USA) Inc. | 1 | $141 |
| Novartis | 8 | $134 |
| Philips North America LLC | 1 | $114 |
| Cvrx, Inc. | 1 | $108 |
| Actelion Pharmaceuticals US, Inc. | 1 | $101 |
| AstraZeneca | 5 | $77 |
| Pfizer | 5 | $71 |
| Celonova Biosciences, Inc. | 1 | $67 |
| Alnylam Pharmaceuticals Inc. | 2 | $56 |
| Amgen | 4 | $56 |
| Getinge USA Sales, LLC | 1 | $53 |
| Silk Road Medical, Inc. | 1 | $45 |
| Amarin Pharma, Inc. | 3 | $45 |
| Acist Medical Systems, Inc. | 1 | $28 |
| Angiodynamics, Inc. | 1 | $21 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Heartflow, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Chiesi USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$1,928
- Micra$677
- OPTIMIZER$282
- Valiant Captivia$261
- Carto 3$216
- COREVALVE EVOLUT R$152
- ENDURANT IIS$150
- TYRX$146
- CardioMEMS HF System$146
- LUTONIX$130
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$124
- TELEMARK MICROCATHETER$124
- XARELTO$122
- NEXLIZET$122
- NEXLETOL$122
- Diamondback Peripheral$119
- Diamondback Coronary$119
- Endurant$117
- EKOSONIC$115
- Resolute$115
How this compares
$15,497 in reported general payments places this provider in the 75th percentile of 1,515 cardiovascular disease providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $19,214 |
| XareltoRivaroxaban | 14 | $12,997 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $71 | $19,21419 claims |
| Johnson & JohnsonXarelto | $485 | $12,99714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,515 cardiovascular disease providers in Texas.
Other cardiovascular disease in Corpus Christi
- Travis TaylorCorpus Christi$676K
- Ramin Farzaneh-FarDallas$17.1M
- Jeffrey GladdenDallas$15.8M
- Ann NavarDallas$14.5M
- David BrabhamAmarillo$11.5M
- Justin GrodinDallas$6.2M
- Christie BallantyneHouston$4.6M
- Syed NaqviHouston$3.6M
- Faisal WahidMcKinney$3.4M
- James FeldmanHouston$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.